Natixis Investment Managers International’s Ionis Pharmaceuticals IONS Stock Holding History

Natixis Investment Managers International’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-16,631	Closed	-$609K	–	441
2016 Q3	$609K	Buy	+16,631	New	+$520K	0.06%	219
2015 Q4	–	Sell	-2,571	Closed	-$104K	–	433
2015 Q3	$104K	Sell	2,571 -3,591	-58%	-$186K	0.01%	381
2015 Q2	$355K	Buy	+6,162	New	+$392K	0.04%	277
2014 Q3	–	Sell	-1,701	Closed	-$59K	–	196
2014 Q2	$59K	Hold	1,701	–	–	0.01%	199
2014 Q1	$74K	Buy	+1,701	New	+$82.5K	0.01%	164

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Natixis Investment Managers International's IONS Position: Q4 2016 in Review

Natixis Investment Managers International sold out of Ionis Pharmaceuticals (IONS) in Q4 2016, closing a stake of 16,631 shares — an estimated $609K sold.

Natixis Investment Managers International first reported a position in IONS in Q1 2014 and held it in 5 quarters. The position peaked at $609K in Q3 2016. 309 funds tracked by Wall St. Rank hold IONS as of Q4 2016.

Natixis Investment Managers International reported no remaining Ionis Pharmaceuticals position as of Q4 2016 after selling out during the quarter.
Natixis Investment Managers International sold 16,631 Ionis Pharmaceuticals shares in Q4 2016, an estimated $609K.
Natixis Investment Managers International first reported a position in Ionis Pharmaceuticals in Q1 2014 and held it in 5 quarters.
Natixis Investment Managers International's Ionis Pharmaceuticals position peaked at $609K in Q3 2016.
309 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q4 2016.

Based on Natixis Investment Managers International's 13F filing for Q4 2016, filed 14 Feb 2017.